Ipamorelin is a synthetic pentapeptide, meaning a peptide containing five amino-acid residues. The original pharmacology paper describes it as a growth hormone secretagogue, a classification used for compounds studied for stimulating growth hormone secretion. [1]
For laboratory and analytical research only. Not for human consumption, medical, diagnostic, therapeutic, or veterinary use.
Identity and research context
Raun and colleagues reported ipamorelin’s peptide sequence and experimental pharmacology. Published research also includes a study of its pharmacokinetics and pharmacodynamics in human volunteers. These studies describe their own materials and protocols; they do not establish the suitability or performance of an AlphaGrade vial. [1] [2]
This reference covers standalone ipamorelin. A combination labeled CJC-1295 plus ipamorelin is a separate material requiring its own component identities and documentation. Studies of individual ingredients do not establish the properties, stability, safety, or effects of a finished blend.
Documentation and lot traceability
Product- or lot-specific documentation may be available depending on the material and lot. Request the current lot’s documentation through Contact. Include the product name and lot identifier. Check that the report identifies the same material and lot; documentation for another brand or lot does not establish the properties of your material.
For ipamorelin, request the documented peptide identity and chemical form. Do not infer a salt form from the name alone. For any combination product, component amounts and modifications require separate confirmation.
AlphaGrade listing
Ipamorelin 10 mg. This is the standalone listing associated with this reference. Check it for current commercial details.
Frequently asked questions
Does “pentapeptide” describe a vial quantity?
No. It describes the number of amino-acid residues in the peptide, not the amount of material in a vial. [1]
Can this reference verify a CJC-1295 combination?
No. Standalone ipamorelin research does not resolve the identity, modifications, proportions or properties of a combination product.
References
- Raun K et al. (1998). Original ipamorelin pharmacology study. DOI: 10.1530/eje.0.1390552. PMID: 9849822. Primary-study record and abstract.
- Human-volunteer study of ipamorelin pharmacokinetics and pharmacodynamics. PMID: 10496658. Primary-study record and abstract.
The cited literature describes the compound or its components. It does not test, certify, or establish the suitability of any material supplied by AlphaGrade.
